XML 77 R5.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' (DEFICIT) EQUITY - USD ($)
shares in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2016 $ 873,000 $ 778,847,000 $ (932,570,000) $ (152,850,000)
Balance (in shares) at Dec. 31, 2016 87,301      
Increase (Decrease) in Shareholders' (Deficit) Equity        
Net loss     (96,012,000) (96,012,000)
Stock options exercised $ 1,000 649,000   650,000
Stock options exercised (in shares) 191      
Issuance of common stock $ 167,000 101,496,000   101,663,000
Issuance of common stock (in shares) 16,675      
Restricted stock award - net of forfeitures $ 21,000 (21,000)    
Restricted stock award - net of forfeitures (in shares) 2,146      
Conversion of debt $ 262,000 117,067,000   117,329,000
Conversion of debt (in shares) 26,160      
Stock option and restricted stock compensation expense   11,119,000   11,119,000
Directors' deferred share units converted $ 1,000 (1,000)    
Directors' deferred share units converted (in shares) 53      
Directors' deferred share unit compensation   206,000   206,000
Balance at Dec. 31, 2017 $ 1,325,000 1,009,362,000 (1,028,582,000) (17,895,000)
Balance (in shares) at Dec. 31, 2017 132,526      
Increase (Decrease) in Shareholders' (Deficit) Equity        
Net loss     (168,843,000) (168,843,000)
Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan $ 9,000 4,292,000   4,301,000
Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan (in shares) 946      
Issuance of common stock $ 158,000 162,354,000   162,512,000
Issuance of common stock (in shares) 15,755      
Stock option and restricted stock compensation expense   16,445,000   16,445,000
Directors' deferred share units converted $ 2,000 (1,000)   1,000
Directors' deferred share units converted (in shares) 173      
Directors' deferred share unit compensation   361,000   361,000
Balance at Dec. 31, 2018 $ 1,494,000 1,192,813,000 (1,183,335,000) $ 10,972,000
Balance (in shares) at Dec. 31, 2018 149,400     149,400
Increase (Decrease) in Shareholders' (Deficit) Equity        
Transition adjustment for ASC 606     14,090,000 $ 14,090,000
Net loss     (104,133,000) (104,133,000)
Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan $ 11,000 2,862,000   2,873,000
Issuance of common stock pursuant to the exercise of stock options and employee stock purchase plan (in shares) 1,150      
Restricted stock award - net of forfeitures $ (4,000) 4,000    
Restricted stock award - net of forfeitures (in shares) (414)      
Stock option and restricted stock compensation expense   13,830,000   13,830,000
Directors' deferred share unit compensation   337,000   337,000
Balance at Dec. 31, 2019 $ 1,501,000 $ 1,209,846,000 $ (1,287,468,000) $ (76,121,000)
Balance (in shares) at Dec. 31, 2019 150,136     150,136